CMOSIS Raises 3 Million Euros in Additional Capital for Corporate Expansion

CMOS image sensor start-up CMOSIS NV has successfully concluded a round of private equity financing from several highly regarded Belgian high-tech investment firms totalling 3 million euros. Lead investor is ING Corporate Investments of Brussels, Belgium, acting as strategic financial partner. The new round of capitalization for CMOSIS is geared towards the ongoing development of innovative CMOS image sensor technologies and further business expansion.

"We are convinced that CMOSIS has the potential to be a leader in the highly innovative market for CMOS image sensor technology," says Tom Bousmans, Private Equity Investment Manager at ING Corporate Investments of Brussels, Belgium. "This is due to their uniquely qualified management and engineering teams, their proven scientific know-how base and long-time market expertise. Through this substantial capital increase, we will secure their continued growth. We believe in the strategic direction of CMOSIS and the market potential for high-end CMOS image sensors."

ING Corporate Investments, a part of ING Belgium, is investing 1.5 million euros in CMOSIS. ING Activator Fund, another ING group member, is investing 0.5 million euros. The rest of the current CMOSIS capitalization round is contributed by Vlaams Innovatiefonds ("Vinnof").

The CMOSIS technology portfolio contains crucial IP related to various advanced aspects of image sensors -- among them high pixel counts at a high fill factor, high-speed functionality, large bit-depth of column ADCs, high dynamic range, TDI (time-delay and integration) implementation in CMOS and novel rad-hard pixel concepts. CMOSIS was founded in November 2007 and received its initial financing by the founders and by Capital-E, a Belgian Venture Capitalist. In March of 2009, the Institute for the Promotion of Innovation by Science and Technology in Flanders granted CMOSIS a substantial R&D subsidy.

"CMOSIS's first 19 months of operation have confirmed that there are vast, still untapped, business opportunities for CMOS image sensors, especially in areas that were considered CCD strongholds," says CMOSIS CEO Luc De Mey. "We are well positioned for a significant share of future industrial and professional CMOS image sensor markets."

De Mey joined CMOSIS in May 2009 as a widely known expert and veteran of the imaging industry. "Recent progress in CMOS image sensor technology, such as dark current and noise performance, will cause conventional CCD technology to lose market share. At CMOSIS, we are focusing on promising machine vision, medical, scientific and space applications." Other CMOSIS principals, besides Luc De Mey (CEO) and Andre Alaerts (Director of Manufacturing), are Guy Meynants (VP R&D) and Lou Hermans (VP Sales and Marketing).

CMOSIS occupies an 800 m2 industrial facility in Antwerp, Belgium, where it operates development labs, device qualification and a 100m2, Class 100, clean room for wafer and device production testing. The recently enlarged premises support the launch of a suite of standard machine-vision CMOS imagers as well as the manufacture of the company's first custom image sensor products. CMOSIS continues expanding its staff by hiring senior personnel for product qualification and manufacturing, as well as quality and customer support operations.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.